Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early ...
The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...
Prostate biopsies in Florida typically cost between $4,864 and $5,334 per procedure, representing a significant burden when a majority of procedures yield benign findings. If the study’s objectives ...
The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...
Daily Mail on MSN
New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds
A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.
Doctors say men should not wait for symptoms to ask about prostate cancer screening.
GAITHERSBURG, Md., May 12, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results